Patenting biotechnological inventions is one of the most legally challenging areas of industrial property law in 2026 – especially following the recent CRISPR decisions of the PTAB and the EPO, as well as the ongoing EU negotiations on the NGT Regulation. Anyone seeking protection for sequences, gene scissors or
